Literature DB >> 22263080

What is the current status of Stereotactic body radiotherapy for stage I non-small cell lung cancer?

Matthias Guckenberger1.   

Abstract

Entities:  

Year:  2011        PMID： 22263080      PMCID： PMC3256527          DOI： 10.3978/j.issn.2072-1439.2011.06.04

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  20 in total

Review 1.  Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).

Authors:  N P Rowell; C J Williams
Journal:  Cochrane Database Syst Rev       Date:  2001

2.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

Review 3.  Sublobar resection: a movement from the Lung Cancer Study Group.

Authors:  Justin D Blasberg; Harvey I Pass; Jessica S Donington
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

4.  Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.

Authors:  Achilles J Fakiris; Ronald C McGarry; Constantin T Yiannoutsos; Lech Papiez; Mark Williams; Mark A Henderson; Robert Timmerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-02-27       Impact factor: 7.038

5.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

6.  Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial.

Authors:  Samuel Bral; Thierry Gevaert; Nadine Linthout; Harijati Versmessen; Christine Collen; Benedikt Engels; Douwe Verdries; Hendrik Everaert; Nicolas Christian; Mark De Ridder; Guy Storme
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-12       Impact factor: 7.038

7.  Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.

Authors:  G S Sibley; T A Jamieson; L B Marks; M S Anscher; L R Prosnitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-01       Impact factor: 7.038

8.  Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.

Authors:  Inga S Grills; Victor S Mangona; Robert Welsh; Gary Chmielewski; Erika McInerney; Shannon Martin; Jennifer Wloch; Hong Ye; Larry L Kestin
Journal:  J Clin Oncol       Date:  2010-01-11       Impact factor: 44.544

9.  Natural history of stage I non-small cell lung cancer: implications for early detection.

Authors:  Dan J Raz; Jason A Zell; S-H Ignatius Ou; David R Gandara; Hoda Anton-Culver; David M Jablons
Journal:  Chest       Date:  2007-05-15       Impact factor: 9.410

10.  Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer.

Authors:  Neil Kopek; Merete Paludan; Jørgen Petersen; Anders Traberg Hansen; Cai Grau; Morten Høyer
Journal:  Radiother Oncol       Date:  2009-06-24       Impact factor: 6.280
View more
  3 in total

1.  LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective.

Authors:  S Adebahr; S Collette; E Shash; M Lambrecht; C Le Pechoux; C Faivre-Finn; D De Ruysscher; H Peulen; J Belderbos; R Dziadziuszko; C Fink; M Guckenberger; C Hurkmans; U Nestle
Journal:  Br J Radiol       Date:  2015-04-15       Impact factor: 3.039

2.  Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis.

Authors:  Daniel H Schanne; Ursula Nestle; Michael Allgäuer; Nicolaus Andratschke; Steffen Appold; Ute Dieckmann; Iris Ernst; Ute Ganswindt; Anca L Grosu; Richard Holy; Michael Molls; Meinhard Nevinny-Stickel; Sabine Semrau; Florian Sterzing; Andrea Wittig; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2014-08-27       Impact factor: 3.621

3.  Double CT imaging can measure the respiratory movement of small pulmonary tumors during stereotactic ablative radiotherapy.

Authors:  Ge Shen; Ying-Jie Wang; Hong-Guo Sheng; Xiao-Ping Duan; Jun-Liang Wang; Wei-Jing Zhang; Zhen-Shan Zhou; Guang-Ying Zhu; Ting-Yi Xia
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.